Latest filingSep 01, 2026Most recent Form 4
IMNN
Imunon, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$794k2 sells
Net open-market-$794k4 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period9transactions
- A · Grants / awards · dominant7 · 78%
- S · Open-market sells2 · 22%
Activity by reported role
A joint filing can contribute to multiple roles9transactions
- GC · dominant4 · 44%
- CHAIR2 · 22%
- CMO2 · 22%
- PRES1 · 11%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (4)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeEylward SusanCommon Stock · Direct
2,896Aug 31, 2026
Tardugno Michael HCommon Stock · Direct
89,875Aug 28, 2026
Faller Douglas VincentCommon Stock · Direct
37,077Aug 28, 2026
Lindborg StacyCommon Stock · Direct
93,254Aug 14, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- TH+$23.6k
- FV+$11.6k
- LS+$10.9k
- ES+$138
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
IMNN transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| IMNN | Tardugno Michael H | CHAIR | grant | 7.37k | $1.17M | A | 0.0% | 09/01 | 08/28 | |
| IMNN | Faller Douglas Vincent | CMO | grant | 3.62k | $580k | A | 0.0% | 09/01 | 08/28 | |
| IMNN | Eylward Susan | GC | sale | 2.52k | -$394k | S | 0.0% | 09/01 | 08/31 | |
| IMNN | Eylward Susan | GC | grant | 2.52k | $404k | A | 0.0% | 09/01 | 08/28 | |
| IMNN | Lindborg Stacy | PRES | grant | 6.61k | $1.09M | A | 0.0% | 08/17 | 08/14 | |
| IMNN | Faller Douglas Vincent | CMO | grant | 3.51k | $580k | A | 0.0% | 08/17 | 08/14 | |
| IMNN | Tardugno Michael H | CHAIR | grant | 7.14k | $1.17M | A | 0.0% | 08/17 | 08/14 | |
| IMNN | Eylward Susan | GC | sale | 2.44k | -$399k | S | 0.0% | 08/17 | 08/17 | |
| IMNN | Eylward Susan | GC | grant | 2.44k | $404k | A | 0.0% | 08/17 | 08/14 |
Imunon, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Imunon, Inc.?
Tardugno Michael H, Faller Douglas Vincent, Eylward Susan, Lindborg Stacy.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Eylward Susan reported a sale on Aug 31, 2026 valued at $394k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $7,942.46. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.